Operating profit of Chong Kun Dang 2015-2023
In 2023, the operating profit of Chong Kun Dang amounted to a record 247 billion South Korean won. This was almost twice as high as the second-highest figure recorded in 2015.
Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharma and biotech M&A activity
Industry overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Global biotech drug sales estimate 2012-2024
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
- Premium Statistic Top pharmaceutical companies by capex growth in 2022
Number of deals
7
- Premium Statistic Planned and actual healthcare and life sciences activity in 2020, by subsector
- Basic Statistic Global number of life sciences sector deals 2013-2021
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
Value of deals
5
- Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
- Basic Statistic Global value of life sciences sector deals 2013-2021
- Basic Statistic Top completed life sciences deals based on value globally 2020
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
Mega-merger: BMS/Celgene
5
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Basic Statistic Bristol-Myers Squibb revenue by segment 2015-2020
- Basic Statistic Celgene's revenue and net income 2006-2018
- Premium Statistic Revenue of Celgene 2016-2018, by therapeutic area
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
2021 outlook
4
- Basic Statistic Expected acquisitions of biopharma companies by type of asset 2021
- Basic Statistic Expected investment in biopharma and diagnostic lab services 2021, by type
- Basic Statistic Expected valuation changes in healthcare and life sciences 2021, by subsector
- Premium Statistic Expected investment changes in biopharma and diagnostic lab services 2021
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Pfizer's ad spending 2006-2023
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Pfizer's ad spending 2006-2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
DART. (March 20, 2024). Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/
DART. "Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won)." Chart. March 20, 2024. Statista. Accessed November 18, 2024. https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/
DART. (2024). Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: November 18, 2024. https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/
DART. "Operating Profit of Chong Kun Dang in South Korea from 2015 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 20 Mar 2024, https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/
DART, Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/ (last visited November 18, 2024)
Operating profit of Chong Kun Dang in South Korea from 2015 to 2023 (in billion South Korean won) [Graph], DART, March 20, 2024. [Online]. Available: https://www.statista.com/statistics/1165921/chong-kun-dang-operating-profit/